Dashboard
Manage Tickers

MAIAMAIA Biotechnology, Inc.

NYSE MAIABiotech.com


$ 3.16 $ 0.02 (0.63 %)    

Friday, 06-Sep-2024 15:59:50 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 446.25 $ -12.35 (-2.68 %)
DIA $ 404.28 $ -3.99 (-0.98 %)
SPY $ 539.90 $ -9.25 (-1.68 %)
TLT $ 99.49 $ -0.01 (-0.01 %)
GLD $ 230.65 $ -1.72 (-0.74 %)
$ 3.17
$ 3.16 x 100
-- x --
-- - --
$ 0.82 - $ 5.99
113,988
na
75.79M
$ 0.83
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-09-2024 06-30-2024 10-Q
2 05-14-2024 03-31-2024 10-Q
3 03-21-2024 12-31-2023 10-K
4 11-07-2023 09-30-2023 10-Q
5 08-08-2023 06-30-2023 10-Q
6 05-08-2023 03-31-2023 10-Q
7 03-24-2023 12-31-2022 10-K
8 11-09-2022 09-30-2022 10-Q
9 08-22-2022 06-30-2022 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

maia-biotechnology-to-present-new-phase-2-clinical-trial-data-at-the-hc-wainwright-26th-annual-global-investment-conference-updates-from-thio-101-to-include-response-rates-and-survival-follow-up
MAIA Biotechnology To Present New Phase 2 ...
09/04/2024 12:34:23

Updates from THIO-101 to include response rates and survival follow-upMAIA Biotechnology, Inc., (NYSE:MAIA) ("MAIA", th...

maia-biotechnologys-lung-cancer-drug-shows-promising-long-term-benefits-in-advanced-patients
MAIA Biotechnology's Lung Cancer Drug Show...
07/23/2024 14:38:11

MAIA Biotechnology's Phase 2 THIO-101 trial shows promising updates for THIO with Regeneron's cemiplimab in advanced NS...

why-sap-shares-are-trading-higher-here-are-20-stocks-moving-premarket
Why SAP Shares Are Trading Higher; Here Ar...
07/23/2024 09:29:04

maia-biotechnology-reports-phase-2-results-for-lung-cancer-treatment-thio
MAIA Biotechnology Reports Phase 2 Results...
07/23/2024 08:12:45

MAIA Biotechnology, Inc., (NYSE:MAIA) ("MAIA", the "Company"), a clinical-stage biopharmaceutical company devel...

why-gamestop-shares-are-trading-lower-by-over-22-here-are-other-stocks-moving-in-fridays-mid-day-session
Why GameStop Shares Are Trading Lower By O...
06/07/2024 17:07:30

maia-biotechnology-announces-validation-of-clinical-and-regulatory-pathways-for-telomere-targeting-cancer-therapies-following-fda-approval-of-gerons-imetelstat
MAIA Biotechnology Announces Validation Of...
06/07/2024 16:31:46

maia-biotechnology-announces-year-to-date-highlights-and-achievements-including-clinical-progress-of-lead-candidate-thio-a-first-in-class-cancer-telomere-targeting-agent-for-non-small-cell-lung-cancer-nsclc
MAIA Biotechnology Announces Year-to-Date ...
06/06/2024 14:08:23

New science for cancer therapy drives powerful value propositionExceptional measures of efficacy by lead drug THIO in Phase 2 c...

12-health-care-stocks-moving-in-wednesdays-intraday-session
12 Health Care Stocks Moving In Wednesday'...
06/05/2024 16:31:03

12-health-care-stocks-moving-in-tuesdays-after-market-session
12 Health Care Stocks Moving In Tuesday's ...
06/04/2024 20:31:10

maia-biotechnology-says-thio-clinical-trial-data-show-efficacy-in-non-small-cell-lung-cancer
MAIA Biotechnology Says THIO Clinical Tria...
06/04/2024 12:42:31

maia-biotechnology-to-present-at-bio-international-convention-2024
MAIA Biotechnology TO Present At BIO Inter...
05/17/2024 12:39:22

maia-biotechnology-announces-independent-director-ms-adelina-louie-ngar-yee-made-an-individual-purchase-of-19665-shares-and-warrants-for-19665-shares-of-common-stock
MAIA Biotechnology Announces Independent D...
04/30/2024 12:32:06

Original seed investor has remained top MAIA stockholderMAIA Biotechnology, Inc., (NYSE:MAIA) ("MAIA", the "Company...

maia-biotechnology-announces-purchase-of-147492-shares-and-warrants-for-147492-shares-by-director-stan-smith-phd-in-private-placement
MAIA Biotechnology Announces Purchase Of 1...
04/29/2024 12:12:06

maia-biotechnology-announces-1m-private-placement-of-494096-shares-at-2034share
MAIA Biotechnology Announces $1M Private P...
04/23/2024 12:52:10

maia-biotechnology-announces-170940--share-purchase-by-director-adelina-louie-in-private-placement
MAIA Biotechnology Announces 170,940 Shar...
03/26/2024 19:03:26

Five independent members of MAIA's Board of Directors purchased shares in the offeringMAIA Biotechnology, Inc., (NYSE:MAIA)...

maia-biotechnology-announces-133m-private-placement-of-06m-shares-at-2295share
MAIA Biotechnology Announces $1.33M Privat...
03/26/2024 12:05:58

MAIA Biotechnology, Inc., (NYSE:MAIA) ("MAIA", the "Company"), a clinical-stage biopharmaceutical company devel...

maia-biotechnology-increased-maximum-aggregate-offering-price-of-shares-of-common-stock-issuable-under-at-market-offering-agreement
MAIA Biotechnology Increased Maximum Aggre...
03/25/2024 20:11:40

maia-biotechnology-announces-170940-share-purchase-by-director-stan-smith-phd-in-a-29m-private-placement
MAIA Biotechnology Announces 170,940 Share...
03/22/2024 19:01:09

Dr. Smith has participated in every MAIA funding roundMAIA Biotechnology, Inc., (NYSE:MAIA) ("MAIA," the "Company&#...

maia-biotechnology-shares-halted-on-code-news-pending
MAIA Biotechnology Shares Halted On Code N...
03/13/2024 17:33:48

maia-biotechnology-announces-efficacy-of-thio-combination-thio-180mg--cemiplimab-achieved-38-overall-response-rate-in-difficult-to-treat-third-line-non-small-cell-lung-cancer
MAIA Biotechnology Announces Efficacy Of T...
03/06/2024 13:50:11

Combination THIO 180mg + cemiplimab achieved 38% overall response rate (ORR) in difficult-to-treat, third-line non-small cell l...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION